No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
PFE241220C20000
- 5.60
- +0.03+0.54%
15min DelayClose Dec 16 16:00 ET
5.60High5.60Low
5.60Open5.57Pre Close4 Volume93 Open Interest20.00Strike Price2.24KTurnover0.00%IV1.39%PremiumDec 20, 2024Expiry Date5.25Intrinsic Value100Multiplier4DDays to Expiry0.35Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma4.98Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Wells Fargo Maintains Pfizer(PFE.US) With Hold Rating, Cuts Target Price to $27
Pfizer (PFE) Gets a Hold From Wells Fargo
Pfizer Options Spot-On: On December 16th, 205.72K Contracts Were Traded, With 3.69 Million Open Interest
On December 16th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 205.72K options for the day, of which put options accounted for 40.24% of the total transactions, and
Sangamo Surges 24% After Roche Ends Development of Hemophilia A Gene Therapy
Insurer Stocks Tumble. Trump Echoes Drug Industry Attacks on PBMs. -- Barrons.com
What To Expect When Pfizer Outlines Its 2025 Financial Outlook On Tuesday?